We're funding 13 research projects across multiple blood cancers
We're delighted to announce funding for 13 new research projects worth over £3million. These 13 research projects add to our overall portfolio of 82 research projects across 27 different institutions in the UK. Each of the projects will focus on a key theme in blood cancer over the next three years.
Our new research projects
🧪 Professor Ian Hitchcock from the University of York wants to understand more about how myeloproliferative neoplasm (MPN) develops to find out whether there might be a way to stop it from happening.
🧪Dr Goedele Maertens from Imperial College London wants to understand how a virus can cause a rare type of lymphoma to try and find new targets for treatment.
🧪Professor Alex Tonks from Cardiff University is studying what drives acute myeloid leukaemia (AML) to try and find new treatment targets for people the disease.
🧪Dr Pramila Krishnamurthy from King's College London wants to understand how the level of chemotherapy people with myelodysplastic syndrome (MDS) receive can affect their quality of life.
🧪Dr Daniel Hodson from the University of Cambridge is looking for new ways to treat non-Hodgkin lymphoma. He wants to find ways to treat people in a kinder way, with fewer side effects.
🧪Dr Robbert Hoogeboom from King's College London wants to know more about how chronic lymphocytic leukaemia (CLL) cells move around the body and start growing.
🧪Professor Claire Edwards from the University of Oxford will look at how fat cells are involved in myeloma progressing as she thinks that fat cells wake up cancer cells and cause the disease to return.
🧪Dr Ingo Ringshausen from the University of Cambridge wants to understand more about how CLL cells can resist treatment as he thinks some cells manage to escape chemotherapy, causing the disease to return.
🧪Professor Dominique Bonnet from the Francis Crick Institute wants to understand more about a cell that she thinks is responsible for AML returning.
🧪Dr Michele Mishto from King's College London wants to understand whether we might be able to harness our immune system to treat MPN.
🧪Professor Anthony Moorman from Newcastle University is trying to find markers that can tell clinicians how much treatment someone with acute lymphoblastic leukaemia (ALL) needs.
🧪Professor Ming-Qing Du from the University of Cambridge will try and work out how MALT lymphoma develops to try and find new ways to treat it.
🧪Dr Dinis Calado from the Francis Crick Institute will try and understand more about why some types of diffuse large B cell lymphoma (DLBCL) stop responding to treatment.
None of this would be possible without your generous support, thank you